ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Hematology Oncology

Top Hematology Oncology Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
OWEN PICKUS D.O.

Hematology Oncology

5,491

$648K

248
204 are 65+

6%
patients receiving schedule two controlled substances

Avg: 17%

12%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 17%

$118
Average prescription price

Avg: $347

ANN TRAYNOR M.D.

Hematology Oncology

3,032

$451K

151
98 are 65+

15%
patients receiving schedule two controlled substances

Avg: 17%

13%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 17%

$149
Average prescription price

Avg: $347

ELIZABETH CONNELLY D.O.

Hematology Oncology

1,450

$383K

251
213 are 65+

16%
patients receiving schedule two controlled substances

Avg: 17%

7%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 17%

$264
Average prescription price

Avg: $347

KURT EBRAHIM D.O.

Hematology Oncology

1,260

$280K

174
133 are 65+

28%
patients receiving schedule two controlled substances

Avg: 17%

12%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 17%

$222
Average prescription price

Avg: $347

DEVON EVANS MD

Hematology Oncology

1,124

$240K

146
103 are 65+

26%
patients receiving schedule two controlled substances

Avg: 17%

17%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 17%

$213
Average prescription price

Avg: $347

DAVID BENTON MD

Hematology Oncology

1,115

$625K

201
167 are 65+

27%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 17%

$560
Average prescription price

Avg: $347

ROGER INHORN M.D.

Hematology Oncology

1,049

$361K

148
106 are 65+

16%
patients receiving schedule two controlled substances

Avg: 17%

11%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 17%

$344
Average prescription price

Avg: $347

NICHOLETTE ERICKSON MD

Hematology Oncology

1,007

$245K

203
159 are 65+

13%
patients receiving schedule two controlled substances

Avg: 17%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 17%

$243
Average prescription price

Avg: $347

ABBY THROWER MD PH.D.

Hematology Oncology

980

$193K

159
125 are 65+

14%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 17%

$197
Average prescription price

Avg: $347

MATTHEW DUGAN D.O.

Hematology Oncology

920

$379K

128
97 are 65+

24%
patients receiving schedule two controlled substances

Avg: 17%

14%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 17%

$412
Average prescription price

Avg: $347

PATRICIA DEISLER MD

Hematology Oncology

870

$90.9K

174
137 are 65+

9%
patients receiving schedule two controlled substances

Avg: 17%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 17%

$105
Average prescription price

Avg: $347

ROBIN LOCKE MD

Hematology Oncology

850

$414K

176
133 are 65+

16%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 17%

$487
Average prescription price

Avg: $347

MAHESH PANDEY MD

Hematology Oncology

848

$767K

113
91 are 65+

15%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 17%

$905
Average prescription price

Avg: $347

KARIN GIORDANO M.D.

Hematology Oncology

847

$499K

141
105 are 65+

26%
patients receiving schedule two controlled substances

Avg: 17%

8%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 17%

$589
Average prescription price

Avg: $347

THOMAS OPENSHAW MD

Hematology Oncology

781

$805K

116
93 are 65+

19%
patients receiving schedule two controlled substances

Avg: 17%

11%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 17%

$1031
Average prescription price

Avg: $347

AMBREEN IJAZ M.D.

Hematology Oncology

775

$441K

119
85 are 65+

23%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 17%

$568
Average prescription price

Avg: $347

CAN ILYAS MD

Hematology Oncology

765

$241K

149
118 are 65+

16%
patients receiving schedule two controlled substances

Avg: 17%

13%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 17%

$315
Average prescription price

Avg: $347

DAVID CALDWELL M.D.

Hematology Oncology

729

$337K

121
76 are 65+

16%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 17%

$462
Average prescription price

Avg: $347

AUDREY GARRETT MD

Hematology Oncology

698

$282K

139
102 are 65+

21%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 17%

$404
Average prescription price

Avg: $347

ASTRID ANDREESCU MD

Hematology Oncology

618

$411K

107
76 are 65+

18%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 17%

$665
Average prescription price

Avg: $347

HANS BOEDEKER MD

Hematology Oncology

572

$203K

73
53 are 65+

37%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 17%

$355
Average prescription price

Avg: $347

TRUDY CHASE MD

Hematology Oncology

529

$148K

89
67 are 65+

12%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 17%

$279
Average prescription price

Avg: $347

SARAH SINCLAIR DO

Hematology Oncology

507

$262K

120
87 are 65+

13%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 17%

$516
Average prescription price

Avg: $347

CHRISTIAN THOMAS MD

Hematology Oncology

482

$222K

94
73 are 65+

32%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 17%

$461
Average prescription price

Avg: $347

HELEN RYAN MD

Hematology Oncology

481

$321K

81
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 17%

$668
Average prescription price

Avg: $347

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank